Regenerative Medicine via Electrogenetics
Vira Regen is developing gene-targeted bioelectronic medicines that use engineered electrical stimulation to modulate gene expression and support tissue regeneration.
.png)
.png)
Our initial focus is accelerating bone regeneration for fresh and nonunion fractures through noninvasive bioelectronic medicine. Future applications include osteoporosis, knee osteoarthritis, cancer electrotherapy, and longevity.
Our Electrogenetics Platform
Unlike traditional stimulation technologies that rely on broad, nonspecific electrical signals, Vira Regen's electrogenetics platform discovers specific stimulation signal combinations designed to target key gene cascades.
This gene-targeted approach is designed to modulate gene expression on demand, supporting tissue regeneration through a new class of bioelectronic medicine.
The Science Behind the Platform
Vira Regen's platform combines noninvasive electrical stimulation, computational biology, and custom machine learning to discover specific signal combinations that target key gene cascades.
.png)
Transforming Recovery
Vira Regen is developing gene-targeted bioelectronic medicines that use Electrogenetics to modulate gene expression and accelerate tissue regeneration.
"Our mission is to transform recovery by developing novel, impactful bioelectronic medicines.”
.png)
Building the Future of Electrogenetics
About Our Science
Learn more about our technology, development progress, and future applications.
What is bioelectronic medicine?
Bioelectronic medicine is an emerging field that uses targeted electrical signals to diagnose, modulate, and treat disease by interacting directly with the body’s natural electrical communication networks. Rather than relying solely on drugs or surgery, bioelectronic therapies influence cellular behavior, nerve signaling, and tissue function with precise electrical stimulation to restore healthy physiology and promote healing.
What makes Vira Regen's approach different?
Vira Regen combines bioelectric stimulation, computational biology, and machine learning to identify gene-targeted stimulation approaches designed to influence key genetic pathways.
What is OsteoVolt™?
OsteoVolt™ is the first application of the Vira Regen platform. It is designed to deliver noninvasive stimulation at the site of injury to accelerate bone healing and regeneration.
What stage of development is Vira Regen in?
Vira Regen has completed preclinical studies demonstrating accelerated healing and continues to advance platform development, scientific validation, and future regulatory milestones.
What therapeutic areas is Vira Regen pursuing?
The platform is initially focused on bone regeneration and healing, with future applications being explored across osteoporosis, osteoarthritis, and additional regenerative medicine opportunities.
Regenerative Medicine via Electrogenetics
